Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

AMS:CTAC - Euronext Amsterdam - NL0000345577 - Common Stock - Currency: EUR

3.39  0 (0%)

Fundamental Rating

6

CTAC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the IT Services industry. Both the profitability and the financial health of CTAC get a neutral evaluation. Nothing too spectacular is happening here. CTAC is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make CTAC a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CTAC was profitable.
CTAC had a positive operating cash flow in the past year.
Each year in the past 5 years CTAC has been profitable.
Each year in the past 5 years CTAC had a positive operating cash flow.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

With a decent Return On Assets value of 5.43%, CTAC is doing good in the industry, outperforming 64.62% of the companies in the same industry.
The Return On Equity of CTAC (12.67%) is comparable to the rest of the industry.
CTAC has a Return On Invested Capital (7.73%) which is in line with its industry peers.
CTAC had an Average Return On Invested Capital over the past 3 years of 7.76%. This is below the industry average of 10.96%.
Industry RankSector Rank
ROA 5.43%
ROE 12.67%
ROIC 7.73%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CTAC has a Profit Margin (3.14%) which is comparable to the rest of the industry.
CTAC's Profit Margin has improved in the last couple of years.
CTAC has a Operating Margin (4.47%) which is comparable to the rest of the industry.
CTAC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.04%, CTAC is doing worse than 60.00% of the companies in the same industry.
CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.47%
PM (TTM) 3.14%
GM 56.04%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTAC is still creating some value.
CTAC has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CTAC has been increased compared to 5 years ago.
CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.00 indicates that CTAC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.00, CTAC is in line with its industry, outperforming 58.46% of the companies in the same industry.
CTAC has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.25, CTAC belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
CTAC has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
CTAC's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. CTAC outperforms 75.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.25
Altman-Z 3
ROIC/WACC1.16
WACC6.69%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.01 indicates that CTAC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.01, CTAC is doing worse than 69.23% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that CTAC should not have too much problems paying its short term obligations.
The Quick ratio of CTAC (1.01) is worse than 66.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 305.73%, which is quite impressive.
CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
Looking at the last year, CTAC shows a decrease in Revenue. The Revenue has decreased by -2.28% in the last year.
Measured over the past years, CTAC shows a quite strong growth in Revenue. The Revenue has been growing by 8.74% on average per year.
EPS 1Y (TTM)305.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%981.94%
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%0.19%

3.2 Future

Based on estimates for the next years, CTAC will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.69% on average per year.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y4.87%
Revenue Next 5Y7.12%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

CTAC is valuated correctly with a Price/Earnings ratio of 12.11.
84.62% of the companies in the same industry are more expensive than CTAC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CTAC to the average of the S&P500 Index (28.79), we can say CTAC is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.23, the valuation of CTAC can be described as reasonable.
Based on the Price/Forward Earnings ratio, CTAC is valued cheaper than 89.23% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CTAC to the average of the S&P500 Index (21.38), we can say CTAC is valued rather cheaply.
Industry RankSector Rank
PE 12.11
Fwd PE 9.23
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTAC is valued cheaper than 90.77% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CTAC is valued cheaply inside the industry as 81.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.85
EV/EBITDA 4.4
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTAC's earnings are expected to grow with 13.69% in the coming years.
PEG (NY)0.26
PEG (5Y)0.5
EPS Next 2Y30.93%
EPS Next 3Y13.69%

6

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.24%.
Compared to an average industry Dividend Yield of 7.47, CTAC pays a bit more dividend than its industry peers.
CTAC's Dividend Yield is a higher than the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years2
Div Non Decr Years5
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

39.80% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
CTAC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP39.8%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (4/25/2025, 7:00:00 PM)

3.39

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.27%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap47.97M
Analysts85
Price Target3.83 (12.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP39.8%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-21.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.34%
Valuation
Industry RankSector Rank
PE 12.11
Fwd PE 9.23
P/S 0.39
P/FCF 6.85
P/OCF 4.66
P/B 1.55
P/tB 11.85
EV/EBITDA 4.4
EPS(TTM)0.28
EY8.26%
EPS(NY)0.37
Fwd EY10.83%
FCF(TTM)0.49
FCFY14.59%
OCF(TTM)0.73
OCFY21.44%
SpS8.79
BVpS2.18
TBVpS0.29
PEG (NY)0.26
PEG (5Y)0.5
Profitability
Industry RankSector Rank
ROA 5.43%
ROE 12.67%
ROCE 14.43%
ROIC 7.73%
ROICexc 10.29%
ROICexgc 140%
OM 4.47%
PM (TTM) 3.14%
GM 56.04%
FCFM 5.63%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexcg growth 3Y-10.84%
ROICexcg growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.25
Debt/EBITDA 0.58
Cap/Depr 63.48%
Cap/Sales 2.64%
Interest Coverage 13.33
Cash Conversion 95.82%
Profit Quality 178.98%
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z 3
F-Score6
WACC6.69%
ROIC/WACC1.16
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)305.73%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%981.94%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y13.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%0.19%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y4.87%
Revenue Next 5Y7.12%
EBIT growth 1Y12.01%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y20.12%
EBIT Next 5YN/A
FCF growth 1Y-21.03%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-3.81%
OCF growth 3Y2.52%
OCF growth 5Y4.91%